KX 001Alternative Names: KX-001
Latest Information Update: 25 Jul 2016
At a glance
- Originator Beijing CoSci Med-Tech
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Common cold
Most Recent Events
- 25 Jul 2016 Investigation in Common cold in China (PO)